Foothill Ranch, CA / Bremerton, WA (September 15, 2020) –  Outpatient orthopedic and sports medicine rehabilitation provider, Intecore Physical Therapy, broadens its care and support for patients experiencing knee pain with the addition of the KneeKG™ System into all of their clinics. Developed by Emovi, the KneeKG™ is used on the knee, like an EKG is for the heart, by providing valuable data that enables the Physical Therapy team to determine the most appropriate patient-specific care plan to restore optimal knee function.

All of Intecore’s Physical Therapy locations – Aliso Viejo, CA; Foothill Ranch, CA; Orange, CA; San Juan Capistrano, CA and Bremerton, WA – will launch the KneeKG™ in their clinics this week.

Knee pain is the second leading cause of chronic pain. One out of five people experiences knee pain during their life due to an injury or pathology such as knee osteoarthritis, patellofemoral syndrome, ACL rupture, or a meniscal tear.

The FDA cleared KneeKG™ is the first in-clinic device that enables healthcare professionals to accurately, objectively, and in real-time,  assess a patient’s knee(s) in 3D while the patient is moving and weight-bearing. In contrast to static information provided by X-ray and MRI, KneeKG™ quickly identifies the biomechanical and functional deficits linked to pain and instabilities of an orthopedic cause such as those associated with knee osteoarthritis, anterior knee pain, and ligament injuries.  By providing a functional and objective knee assessment with a higher correlation to the symptoms, the KneeKG™ enables the clinician to develop a more focused treatment plan to significantly improve patients’ quality of life, pain, and functional limitations.

“Over the last 20+ years, I’ve been working and helping people find relief from acute and chronic knee pain, and what I know is the vicious cycle of rest and medications will do absolutely nothing to get to the root cause of most types of knee pain,” said Andrew Vertson, Intecore PT Owner and Doctor of Physical Therapy. “Introducing the KneeKG™ into our clinic allows us to offer the latest technology to our patients and, more efficiently, diagnose and, ultimately, mitigate their knee pain.”

Continued Verston, “The KneeKG™ perfectly supports our emphasis on patient education and an individual focus on patient care to successfully return our patients to full function and enhance their quality of life.”

“Knee pain affects one-third of Americans at some point during their life. Our commitment to enabling physicians to improve outcomes for patients with knee pain worldwide will always be our motivation,” said Michelle Laflamme, president and CEO of Emovi, Inc. “We are thrilled to be working with all of the Intecore offices as they introduce the KneeKG™ to strategically care for their patients that suffer from chronic and acute pain.”

###

About Intecore Physical Therapy

Intecore Physical Therapy is a progressive, physical therapist-owned practice that, over the past 14+ years, has become known as the place for quality patient care and positive outcomes. Our passionate and dedicated team of professionals helps active people from 8 to 80 years young get back to doing what they love post-op or injury. Our staff listens to our patients, and they are kind and approachable while providing hands-on/manual therapy that helps to fulfill our mission of …“Return People to Life.”

About Emovi Inc.

Headquartered in Montreal, Emovi is a medical device company that develops products for knee joint assessment to restore the patient quality of life. In partnership with the Quebec university research community, including the CRCHUM, École de Technologie supérieure (ÉTS), and TELUQ, Emovi completed the development of the KneeKG™, a unique clinical tool evaluating knee functional deficiencies linked to patients’ symptoms and pathology progression. Emovi owns multiple patents and the exclusive worldwide license to commercialize KneeKG™. https://emovi.ca           The KneeKG™ is FDA indicated for appropriate assessment of the 3D knee motion for patients who have impaired movement functions of an orthopedic cause.  It is intended to provide information used for physicial evaluation and treatment planning

Olympian Bruny Surin Invests in Global Medical Device Company

Currently a brand ambassador for Emovi, Inc. Surin expands partnership as an investor

Montreal, Quebec (September, 2020) – Emovi, Inc. today announced that Canadian Olympian Bruny Surin, a KneeKG™ patient and Emovi Ambassador, has extended his support and became an investor in the company. The advanced partnership will support the organization’s commercialization efforts of the KneeKG. This first in-clinic device meets the global need for measuring knee function with objective and quantifiable data associated with mechanical knee markers and functional deficiencies.

“The Knee Kinesiography with KneeKG has helped tremendously! As a result of my personalized treatment, I went from pain that I rated as ten out of ten, to no pain at all. I fundamentally believe in the benefits of this technology and am very excited to join Emovi as an investor and new partner,” said Bruny Surin.

“I am sincerely delighted to count Bruny among our team of partners,” said Michelle Laflamme, CEO of Emovi. “Since the start of his journey with the KneeKG, he has continuously supported Emovi and has been an exemplary ambassador.”

Continued Laflamme, “The level of confidence that Bruny has in our product further validates the technology and the hard work the team has put into its development. We are thrilled to have Bruny’s support as we continue to advance our product in the market.”

After a long sprinting career, which included a gold medal win in 4×100 meter relay at the 1996 Olympics, Surin began experiencing knee pain in 2014. Despite numerous physiotherapy visits, the pain in his knee remained. After additional evaluations, Surin’s doctor recommended that he complete a Knee Kinesiography with the KneeKG to identify the biomechanical factors causing the pain. The results assisted his doctor in identifying factors related to the progression of knee osteoarthritis (OA), and a personalized treatment program was adapted. All traces of pain were eliminated, allowing him to return to his active lifestyle.

According to Surin, “the biomechanical explanations were related to exactly how I felt. This direct correlation encouraged me to do the suggested exercises. Indeed, a retest showed all the factors related to the progression of OA of the knee had disappeared.”

Still very involved in the world of sport, the former Olympian commented, “this innovative technology is an excellent benefit to the athletes of tomorrow. It not only brings relief from their pain but also ensures the health of their post-career knees.”

The financial terms of this agreement were not disclosed.

###

About Emovi Inc.

Headquartered in Montreal, Emovi is a medical device company that develops products for knee joint assessment to restore the patient’s quality of life. In partnership with the Quebec university research community, including the CRCHUM, École de Technologie supérieure (ÉTS), and TELUQ, Emovi completed the development of the KneeKG, a unique clinical tool evaluating knee functional deficiencies linked to patients’ symptoms and pathology progression. Emovi owns multiple patents and the exclusive worldwide license to commercialize KneeKG. https://emovi.ca

The KneeKG is FDA indicated for appropriate assessment of the 3D knee motion for patients who have impaired movement functions of an orthopedic cause.  It is intended to provide information used for physical evaluation and treatment planning purposes.

El Paso, Texas (September 8, 2020) –  FYZICAL Therapy and Balance Centers – El Paso, announces today the launch of KneeKG^TM into all four of their locations. Developed by Emovi, the KneeKG is for the knee, like an EKG is for the heart and provides valuable data that enables physicians and other healthcare professionals to determine the most appropriate patient-specific care plan to restore optimal knee function.

Knee pain is the second leading cause of chronic pain. One out of five people experiences knee pain during their life due to an injury or pathology such as knee osteoarthritis, patellofemoral syndrome, ACL rupture, or a meniscal tear.

The FDA cleared KneeKG is the first in-clinic device that enables healthcare professionals to accurately, objectively, and in real-time,  assess a patient’s knee(s) in 3D while the patient is moving and weight-bearing. In contrast to static information provided by X-ray and magnetic resonance imaging (MRI), KneeKG quickly identifies the biomechanical and functional deficits linked to pain and instabilities of an orthopedic cause such as those associated with knee osteoarthritis, anterior knee pain and ligament injuries.  By providing a functional and objective knee assessment with a higher correlation to the symptoms, the KneeKG enables the clinician to develop a more focused treatment plan to significantly improve patients’ quality of life, pain, and functional limitations.

“At FYZICAL, we consistently aim to advance our services by ensuring we provide the most relevant therapeutic techniques and state-of-the-art-technology in all of our clinics,” said Luis Zuniga, President of FYZICAL PT, DPT, CHT, MTC. “Introducing the KneeKG into our clinics provides an incredible tool for our therapists to more efficiently diagnose knee pain to improve strength, flexibility, balance, and, ultimately, mitigate patients’ knee pain.”

Continued Zuniga, “The KneeKG perfectly supports our emphasis on customized patient care and is an extremely valuable tool to support our partnership with the El Paso Rhinos and our initiatives with the Live Active El Paso platform.”

“Knee pain affects one-third of Americans at some point during their life, and the KneeKG is positioned as a solution to improve the current standard of care by providing real-time, quantifiable data that objectively and accurately assess dynamic knee function,” said Michelle Laflamme, president and CEO of Emovi, Inc. “We are delighted to be working with the FYZICAL clinics in El Paso as they introduce the KneeKG to advance care options for their patients who suffer from chronic and acute knee pain.”

The KneeKG is available at all El Paso FYZICAL locations.

###

About FYZICAL Therapy and Balance Centers 

FYZICAL Therapy and Balance Centers are actively changing the healthcare landscape by providing patients with wellness programs and clinical care in Fall Prevention, Orthopedic, and Vestibular Rehabilitation. With five locations in El Paso, FYZICAL is committed to using the most relevant therapeutic techniques and current state-of-the-art technology. For more information, visit: https://www.fyzical.com/el-paso.

About Emovi Inc.

Headquartered in Montreal, Emovi is a medical device company that develops products for knee joint assessment to restore the patients’ quality of life. In partnership with the Quebec university research community, including the CRCHUM, École de Technologie supérieure (ÉTS), and TELUQ, Emovi completed the development of the KneeKG, a unique clinical tool evaluating knee functional deficiencies linked to patients’ symptoms and pathology progression. Emovi owns multiple patents and the exclusive worldwide license to commercialize KneeKG. https://emovi.ca

The KneeKG is FDA indicated for appropriate assessment of the 3D knee motion for patients who have impaired movement functions of an orthopedic cause.  It is intended to provide information used for physical evaluation and treatment planning purposes.